Spots Global Cancer Trial Database for cell
Every month we try and update this database with for cell cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (RCC) | NCT00100685 | Renal Cell Carc... Metastases | Volociximab (an... | 18 Years - | Abbott | |
Study of M200 (Volociximab) in Patients With Metastatic Renal Cell Carcinoma (RCC) | NCT00100685 | Renal Cell Carc... Metastases | Volociximab (an... | 18 Years - | Abbott | |
A Study of DC-CIK Immunotherapy in the Treatment of Solid Tumors | NCT04476641 | Liver Cancer Kidney Cancer Nasopharyngeal ... Lung Cancer Colorectal Canc... Breast Cancer | CELL | 18 Years - 75 Years | Sun Yat-sen University | |
Efficacy Study of Sunitinib and Everolimus (Rotational vs Sequential Arm) in Pats. With m Clear Cell Renal Cancer | NCT01784978 | Metastatic Rena... | Sunitinib Everolimus | 18 Years - | Associació per a la Recerca Oncologica, Spain | |
Study of IMO-2055 in Metastatic or Locally Recurrent Clear Cell Renal Carcinoma | NCT00729053 | Renal Cell Carc... | IMO-2055 | 18 Years - | Idera Pharmaceuticals, Inc. | |
Utility of Primary Glioblastoma Cell Lines | NCT04180046 | Tumor Brain Tumor | - | Neuromed IRCCS | ||
Matched Unrelated Donor Transplant for Metastatic Renal Cell Carcinoma | NCT00318110 | Metastatic Rena... | NST using MUD f... | 18 Years - 65 Years | Center for International Blood and Marrow Transplant Research | |
Conservative Management With Isolated Sentinel Lymph Node Biopsy in Vulvar Cancer Patients. | NCT00315159 | Vulvar Cancer | Sentinel Node B... | 18 Years - | Women and Infants Hospital of Rhode Island | |
A Study of DC-CIK Immunotherapy in the Treatment of Solid Tumors | NCT04476641 | Liver Cancer Kidney Cancer Nasopharyngeal ... Lung Cancer Colorectal Canc... Breast Cancer | CELL | 18 Years - 75 Years | Sun Yat-sen University | |
Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation | NCT01596699 | Myeloid Maligna... Bone Marrow Fai... Transfusion-dep... Congenital Immu... Metabolic Disea... Severe Immune D... | Alemtuzumab Busulfan Fludarabine Clofarabine | 3 Months - 30 Years | University of California, San Francisco | |
Exploratory Study Evaluating Fluorodeoxyglucose - Position Emission Tomography as a Predictive Marker for Therapy With RAD001 in Metastatic Renal Cell Cancer | NCT00529802 | Carcinoma, Rena... | RAD001 | 18 Years - | University of Chicago | |
Phase II Study in Patients With Recurrent Non-Small-Cell Lung Cancer | NCT00063388 | Non-Small-Cell ... | Cetuximab | 18 Years - | Eli Lilly and Company | |
Conservative Management With Isolated Sentinel Lymph Node Biopsy in Vulvar Cancer Patients. | NCT00315159 | Vulvar Cancer | Sentinel Node B... | 18 Years - | Women and Infants Hospital of Rhode Island |